Vision on the Road: rehabilitation to improve driving-related vision after stroke

Diagnostics and Rehabilitation of Post-stroke Visual Field Loss Using Innovative Visual Field Evaluation. The Impact of Losing Driving Privileges

Not applicable Interventional University of South-Eastern Norway · NCT07147660

This trial will try home-based compensatory vision training to see if it helps people with visual field loss after stroke improve everyday visual function and compensation compared with standard care.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment52 (estimated)
Ages20 Years to 85 Years
SexAll
SponsorUniversity of South-Eastern Norway Academic / other
Locations2 sites (Kongsberg and 1 other locations)
Trial IDNCT07147660 on ClinicalTrials.gov

What this trial studies

This is an open, randomized, controlled, semi–cross-over trial comparing 8 weeks of home-based compensatory scanning training to standard care in adults with visual field loss after stroke. Participants are allocated to immediate or delayed training, keep a training diary, and receive weekly phone follow-ups; assessments occur at baseline and at multiple follow-up points up to 28 weeks. The primary focus is on functional vision outcomes and on how participants perceive their ability to compensate for field loss in daily activities, particularly in traffic situations. Data collection requires travel to Oslo for testing and uses online training modules for the home component.

Who should consider this trial

Good fit: Adults aged 20–85 with visual field defects after stroke, who had a Norwegian Class 1 driving licence revoked within the past five years, speak a Scandinavian language, can give written consent, own a personal computer, and can travel to Oslo for assessments.

Not a fit: People with visual neglect or strabismus, eye disease or other medical conditions that already fail Norwegian Class 1 driving health requirements, significant cognitive impairment, dementia, or severe psychiatric illness are excluded and unlikely to benefit from this intervention.

Why it matters

Potential benefit: If successful, the training could help people with post-stroke visual field loss improve everyday visual functioning and compensatory strategies relevant to driving safety.

How similar studies have performed: Previous studies of compensatory scanning training have shown improvements in scanning behavior and some functional tasks, but evidence for restoring driving eligibility or broad real-world driving improvements is limited and mixed.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion criteria:

* Adults aged 20-85 years with a visual field defect following stroke
* Norwegian Class 1 driving licence revoked no more than five years ago
* Speak a Scandinavian language
* Able to provide written informed consent
* Motivated and willing to participate in study activities for a total of 20 to 28 weeks
* Own a personal computer (for digital follow-up and online vision training)
* Able to travel to Oslo for data collection

Exclusion criteria:

* Presence of strabismus and/or visual neglect
* Eye disease or other health conditions that do not meet the health requirements for a Norwegian Class 1 driver's license
* Cognitive impairment, dementia, severe psychiatric diagnosis, or inability to provide written informed consent

Where this trial is running

Kongsberg and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions StrokeVisual Field LossHemianopiaVision rehabilitationCompensatory strategiesVisual field lossLoss of drivers licensevision training
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.